Craniofacial Resection for the Anterior Skull Base Tumors.
- Author:
Sung Uk KUH
1
;
Kyu Sung LEE
;
Eun Chang CHOI
Author Information
1. Department of Neurosurgery, Yonsei University Medical College, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Craniofacial resection;
Anterior skull base tumor
- MeSH:
Carcinoma, Adenoid Cystic;
Carcinoma, Squamous Cell;
Drug Therapy;
Fibroma, Ossifying;
Hemangioma, Cavernous;
Humans;
Nasal Cavity;
Neurilemmoma;
Orbit;
Osteoma;
Radiotherapy;
Recurrence;
Rhabdomyosarcoma;
Rupture;
Skull Base*;
Skull*
- From:Journal of Korean Neurosurgical Society
1996;25(9):1808-1814
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Craniogacial resection(CFR) is an ideal approaches for tumors involving the anterior skull base. This technique may be used for benign and malignant tumors arising from the paranasal sinus, nasal cavity, and orbit that extend into the anterior skull base. Recently, we have experienced 12 cases of craniogacial resection for anterior skull ase tumors. Most of them were recurrent tumors, and received previous local excision, preoperative radiotherapy, or chemotherapy before craniofacial resection. Histologic types of tumors included 6 squamous cell carcinomas, one each of adenoid cystic carcinoma, rhabdomyosarcoma, osteoma, ossifying fibroma, cavernous hemangioma, and malignant schwannoma. Two patients died after surgery; one from recurrent infection and the other from rupture of the tumor invaded ICA. Four malignant tumors recurred after the CFR. Remaining 5 patients are doing well without tumor recurrence. In conclusion, CFR is a commendable procedure for anterior skull base tumors, providing cure for benign tu mors and at least a local control for malignancies.
